Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2006Annals of the New York Academy of Sciences

Preliminary data support a large prospective randomized trial of doxycycline to prevent aneurysm expansion by inhibiting proteolysis and inflammatory responses.

View Full Paper
Ask AI
Bookmark
Share

Why the study?

Do pharmacological approaches like doxycycline and ACE inhibitors prevent abdominal aortic aneurysm enlargement and rupture?

Population

Patients with abdominal aortic aneurysm (AAA), specifically small AAAs

Design

Review

Authors

MRMark E. RentschlerBBB. Timothy Baxter

Discussion

Loading...

Member takes

Overview

Does not support doxycycline for AAA; leaves open efficacy pending large randomized trials.

Structured PICO

Do pharmacological approaches like doxycycline and ACE inhibitors prevent abdominal aortic aneurysm enlargement and rupture?

P
Population
Patients with abdominal aortic aneurysm (AAA), specifically small AAAs
I
Intervention
Pharmacological approaches including tetracycline antibiotics (doxycycline) and antihypertensive medications affecting the angiotensin-converting enzyme system
O
Outcome
Prevention of aneurysm expansion and rupture

Pharmacological therapies targeting inflammation and proteolysis, such as doxycycline, show potential for preventing abdominal aortic aneurysm expansion and warrant further investigation in large randomized trials.

Cite This Study

Rentschler et al. (2006) studied this question.

synapsesocial.com/papers/6a70cd245d37378ac1ddf460https://doi.org/10.1196/annals.1383.003
View Full Paper
Ask AI
Bookmark
Share